| Financial Year |
March 31 2020 |
| Monetary Funds |
250,415,860.76 |
| Held-for-trading Financial Assets |
9,000,000.00 |
| Notes Receivable |
53,766,791.85 |
| Accounts Receivable |
404,900,803.33 |
| Advances to Suppliers |
468,440,090.35 |
| Other Receivables |
62,086,257.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
28,075.22 |
| Dividend Receivable |
28,091,705.77 |
| Inventories |
712,024,048.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
130,718,180.05 |
| Total Current Assets |
2,091,352,032.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,367,197,025.24 |
| Investment Properties |
-- |
| Fixed Assetes |
167,497,531.15 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,791,680.70 |
| R&D expenses |
-- |
| Goodwill |
596,069,701.30 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
6,346,113.35 |
| Other Non-Current Assets |
258,554,751.47 |
| Sub-Total of Non-Current Assets |
3,735,537,678.24 |
| Total Assets |
5,826,889,710.61 |
| Short-Term Loans |
42,075,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,034,676,804.72 |
| Accounts Received In Advance |
585,478,784.40 |
| Employee Compensation Payable |
273,016.58 |
| Taxes Payable |
391,107,942.79 |
| Interest Payable |
495,888,631.03 |
| Dividend Payable |
43,446,153.90 |
| Other payables |
6,145,447,489.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
636,463,516.13 |
| Other Current Liabilities |
3,304,325,000.00 |
| Sub-Total of Current Liabilities |
14,139,847,553.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
88,120,868.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,504,401,027.98 |
| Deferred Income Tax Liabilities |
3,037,852.42 |
| Other Non-Current Liabilities |
3,048,941,000.00 |
| Sub-Total of Non-Current Liabilities |
6,719,213,764.49 |
| Total Liabilities |
20,859,061,318.25 |
| Paid-In Capital(Or Share Stock) |
3,989,440,192.00 |
| Capital Surplus |
9,048,265,511.95 |
| Surplus Reserve |
286,311,762.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-27,793,045,182.70 |
| Minority Stockholder's Interest |
-533,325,587.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-14,498,846,020.16 |
| Owner's Equity（Stockholder's Equity） |
-15,032,171,607.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,826,889,710.61 |
